Last Update Time:
12-Mar-2025 16:00:00
ISIN:
INE092A01019
Sector:
Chemicals
Symbol:
TATACHEM
Tata Chemicals Limited
₹806.70
₹-9.20
(-1.13%)
▼
Prev. Close
₹815.90
Open
₹815.10
Close
₹806.00
Range
₹766.37 - ₹847.04
High
₹824.60
Low
₹797.10
Ind. Close
₹0.00
VWAP
₹808.70
The current stock price of Tata Chemicals Limited is ₹806.70, with a target price range between ₹766.37 and ₹847.04. The stock has experienced a price change of ₹-9.20 (-1.13%), reflecting recent market volatility.
Today's opening price was ₹815.10, while the previous close stood at ₹815.90.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Tata Chemicals Limited Price Chart
Tata Chemicals Limited Pre Open Market Overview: 12-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 815.1
- Previous Close Price: 815.9
- Change: -0.80%
- Total Traded Volume: 594
- Total Buy Quantity: 10,645
- Total Sell Quantity: 11,779
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 813.35 | 32.00 | 0.00 |
| 814.75 | 1.00 | 0.00 |
| 814.90 | 484.00 | 0.00 |
| 815.00 | 307.00 | 0.00 |
| 815.10 | 1,250.00 | 0.00 |
| 815.90 | 0.00 | 20.00 |
| 816.00 | 0.00 | 16.00 |
| 816.50 | 0.00 | 9.00 |
| 818.00 | 0.00 | 25.00 |
| 819.80 | 0.00 | 100.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 10645
Total Sell Quantity: 11779
Shareholding Patterns of Tata Chemicals Limited
Key Trade Statistics of Tata Chemicals Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 4.96 |
| Traded Value (₹ Cr.) | 40.08 |
| Total Market Cap (₹ Cr.) | 20,551.19 |
| Free Float Market Cap (₹ Cr.) | 12,589.21 |
| Impact cost | 0.03 |
| Quantity Traded | 495,651.00 |
| Deliverable Quantity | 188,877.00 |
| % of Quantity to Traded | 38.11 |
| Security VaR | 12.82 |
| Index VaR | N/A |
| VaR Margin | 12.82 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 16.32 |
| Face Value | 10 |
Key Price Statistics of Tata Chemicals Limited
The 52-week high for Tata Chemicals Limited was ₹1,247.35, recorded on 21-Oct-2024. On the other hand, the 52-week low stands at ₹756.00, with the lowest value recorded on 03-Mar-2025.
The upper band for trading is ₹897.45, and the lower band is ₹734.35. The price band is No Band%.
The stock's daily volatility stands at 2.01, while the annualized volatility is 38.40. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (21-Oct-2024) | 1,247.35 |
| 52 Week Low (03-Mar-2025) | 756.00 |
| Upper Band | 897.45 |
| Lower Band | 734.35 |
| Price Band (%) | No Band |
| Daily Volatility | 2.01 |
| Annualised Volatility | 38.40 |
| Tick Size | 0.05 |
Key Securities Statistics of Tata Chemicals Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 01-Apr-1999 |
| Adjusted P/E | 39.77 |
| Symbol P/E | 0 |
| Index | NIFTY MIDCAP 100 |
| Macro-Economic Sector | Commodities |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Basic Industry | Commodity Chemicals |
Security Status of Tata Chemicals Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Tata Chemicals Limited
| Subject | Date |
|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 12-Mar-2025 |
| Credit Rating- New | 27-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 24-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 19-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Feb-2025 |
| Copy of Newspaper Publication | 04-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 03-Feb-2025 |
| Integrated Filing- Financial | 03-Feb-2025 |
Corporate Actions of Tata Chemicals Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Dividend - Rs 15 Per Share | 12-Jun-2024 |
| 10 | Annual General Meeting/Dividend - Rs 17.50 Per Share | 14-Jun-2023 |
| 10 | Annual General Meeting/Dividend - Rs 12.5 Per Share | 15-Jun-2022 |
| 10 | Annual General Meeting/Dividend - Rs 10 Per Share | 14-Jun-2021 |
| 10 | Annual General Meeting/Dividend - Rs 11 Per Share | 22-Jun-2020 |
| 10 | Demerger | 04-Mar-2020 |
| 10 | Annual General Meeting/ Dividend - Rs 12.50 Per Share | 28-Jun-2019 |
| 10 | Annual General Meeting/Final Dividend- Rs 11 Per Share/ Special Dividend- Rs 11 Per Share | 16-Jul-2018 |
| 10 | Annual General Meeting/ Dividend -Rs 11/- Per Share | 31-Jul-2017 |
| 10 | Annual General Meeting/Dividend Rs 10/- Per Share | 02-Aug-2016 |
| 10 | Annual General Meeting/Dividend Rs 10/- Per Share And Special Dividend Rs.2.50/-Per Share | 31-Jul-2015 |
| 10 | Annual General Meeting / Dividend - Rs 10/- Per Share | 08-Aug-2014 |
| 10 | Annual General Meeting / Dividend - Rs.10/- Per Equity Share | 12-Aug-2013 |
| 10 | Annual General Meeting/Dividend Rs 10 Per Share | 08-Aug-2012 |
| 10 | Annual General Meeting And Dividend Rs.10/- Per Share | 25-Jul-2011 |
| 10 | Dividend-Rs.9/- Per Share | 02-Jul-2010 |
| 10 | Agm/Div-Rs.9/- Per Share | 14-Jul-2009 |
| 10 | Agm/Div-Rs.9 Per Share | 18-Jul-2008 |
| 10 | Agm/Div-Rs.8/- Per Sh | 06-Jul-2007 |
| 10 | Agm/Div-Rs.7/- Per Sh | 29-Jun-2006 |
Board Meetings of Tata Chemicals Limited
Financial Results of Tata Chemicals Limited
Company Directory of Tata Chemicals Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.tatachemicals.com | Head Office/ Corporate Office | Bombay House 24, Homi Mody Street Fort | MUMBAI |
| www.tatachemicals.com | Registered Office | Bombay House 24, Homi Mody Street, Fort, | MUMBAI |
| www.tatachemicals.com | Transfer Agent | MUFG Intime India Private Limited C-101, 1st Floor, 247 Park Lal Bahadur Shastri Marg Vikhroli West | MUMBAI |
Insider Trading of Tata Chemicals Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Tata Sons Private Limited | 1213510673 | Buy |
| 7(2) | Tata Sons Private Limited | 283064223 | Buy |
| 7(2) | Tata Sons Private Limited | 760705565 | Buy |
| 7(2) | Tata Sons Private Limited | 502370214 | Buy |
| 7(2) | Tata Sons Private Limited | 8808514 | Buy |
| 7(2) | Tata Sons Private Limited | 635674021 | Buy |
| 7(2) | Tata Sons Private Limited | 130691334 | Buy |
| 7(2) | Tata Sons Private Limited | 626353353 | Buy |
| 7(2) | Tata Sons Private Limited | 41814722 | Buy |
| 7(2) | Tata Sons Private Limited | 606486269 | Buy |
| 7(2) | Tata Sons Private Limited | 50355787 | Buy |
| 7(2) | Tata Sons Private Limited | 772844673 | Buy |
| 7(2) | Tata Sons Private Limited | 1215190242 | Buy |
| 7(2) | Tata Sons Private Limited | 31682202 | Buy |
| 7(2) | Tata Sons Private Limited | 800812562 | Buy |
| 7(2) | Tata Sons Private Limited | 75906614 | Buy |
| 7(2) | Tata Sons Private Limited | 1111238161 | Buy |
| 7(2) | Tata Sons Private Limited | 356446795 | Buy |
| 7(2) | Tata Sons Private Limited | 4202166 | Buy |
| 7(2) | Tata Consumer Products Limited (formerly Tata Global Beverages Limited) | 532669110 | Sell |
Annual Reports of Tata Chemicals Limited
Investor Complaints of Tata Chemicals Limited
Event Calendar of Tata Chemicals Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To consider and approve Audited Financial Results for the year ended March 31, 2010 and recommendation of dividend for the financial year 2009-10, if any, |
| Financial Results | To consider and take on record the Financial Results of the Company, for the third quarter ended December 31,2010. |
| Results/Dividend | To consider and approve Audited Financial Results for the year ended March 31, 2011 and recommendation of dividend for the financial year 2010-11, if any, |
| Financial Results | Inter-alia to consider and approve the Financial Results of the Company for the first quarter ended June 30, 2011. |
| Results/Dividend | To consider and approve Audited Financial Results for the year ended March 31, 2012 and recommendation of dividend for the financial year 2011-12, if any. |
| Financial Results | Inter-alia to consider and approve the Financial Results of the Company for the first quarter ended June 30, 2012. |
| Financial Results | To consider and approve the Financial Results of the Company for the second quarter ended September 30, 2012. |
| Financial Results | To consider and take on record the Financial Results of the Company, for the third quarter ended December 31, 2012. |
| Results/Dividend | To consider and approve Audited Financial Results for the year ended March 31, 2013 and recommendation of dividend for the financial year 2012-13, if any. |
| Results | Inter-alia, to consider and approve the Financial Results of the Company for the first quarter ended June 30, 2013. |
| Results | Inter-alia, to consider and approve the Financial Results of the Company for the second quarter and half year ended September 30, 2013. |
| Results | To consider and take on record the Financial Results of the Company for the third quarter ended December 31, 2013. |
| Results/Dividend | To consider and approve Audited Financial Results for the year ended March 31, 2014 and recommendation of dividend for the financial year 2013-14, if any. |
| Results | To consider and approve the Financial Results of the Company for the first quarter ended June 30, 2014. |
| Results | To consider and approve the Financial Results of the Company for the second quarter and half year ended September 30, 2014. |
| Results | To consider and take on record the Financial Results of the Company for the third quarter ended December 31, 2014. |
| Results/Dividend | to consider and approve Audited Financial Results for the year ended March 31, 2015 and recommendation of dividend for the financial year 2014-15, if any. |
| Results | Inter-alia, to consider and approve the Financial Results of the Company for the first quarter ended June 30, 2015. |
| Results | To consider and approve the Financial Results of the Company for the second quarter and half year ended September 30, 2015. |
| Results | inter alia, to consider the Audited Standalone and Unaudited Consolidated financial results (with limited review) of the Company for the quarter and nine months ended December 31, 2015 |
| Results/Dividend | inter-alia, to consider: i) the Audited Financial Results of the Company (both Standalone & Consolidated) and ii) recommendation of dividend, if any for the year ended March 31, 2016. |
| Results | inter-alia, to consider the financial results of the Company for the first quarter ended June 30, 2016. |
| Results | inter alia, to consider financial results of the Company for the second quarter ended September 30, 2016. |
| Results | Inter alia, to consider financial results of the Company for the quarter and nine months ended December 31, 2016. |
| Results/Dividend | inter-alia, to consider: i) the Audited Financial Results of the Company (both Standalone & Consolidated) and ii) recommendation of dividend, if any for the year ended March 31, 2017. |
| Results | inter-alia, to consider financial results of the Company for the first quarter ended June 30, 2017. |
| Results | , inter-alia, to consider financial results of the Company for the quarter and nine months ending December 31, 2017. |
| Financial Results/Dividend | A meeting of the Board of Directors of the Company will be held on Monday, 7th May, 2018, inter-alia, to consider:i) the Audited Financial Results of the Company (both Standalone & Consolidated) and ii) recommendation of dividend, if anyfor the year ended March 31, 2018. |
| Financial Results/Dividend | TATACHEM : 18-May-2018 : The Company has informed the Exchange that a Board meeting to be held on May 07, 2018 has been re-scheduled to May 18, 2018, to consider and approve the annual audited financial results for the period ended March 31, 2018 and dividend, if any. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | Inter alia, to consider financial results of the Company for the second quarter and half year ended September 30, 2019. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Tata Chemicals Limited has informed the Exchange about Board Meeting to be held on 09-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Tata Chemicals Limited has informed the Exchange about Board Meeting to be held on 27-Oct-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Tata Chemicals Limited
Voting Results of Tata Chemicals Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 26-JUN-2024 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2024, together with the Reports of the Board of Directors and Auditors thereon |
| 26-JUN-2024 | AGM | Ratification of Remuneration of Cost Auditors |
| 26-JUN-2024 | AGM | Re-appointment of Mr. K.B.S. Anand (DIN: 03518282) as an Independent Director of the Company |
| 26-JUN-2024 | AGM | Re-appointment of Dr. C. V. Natraj (DIN: 07132764) as an Independent Director of the Company |
| 26-JUN-2024 | AGM | To appoint a Director in place of Mr. S. Padmanabhan (DIN: 00306299), who retires by rotation and being eligible, offers himself for re-appointment |
| 26-JUN-2024 | AGM | To declare dividend on the Ordinary Shares for the financial year ended March 31, 2024 |
| 26-JUN-2024 | AGM | To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, together with the Report of the Auditors thereon |
| 26-JUN-2023 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023, together with the Reports of the Board of Directors and Auditors thereon. |
| 26-JUN-2023 | AGM | Ratification of Remuneration of Cost Auditors. |
| 26-JUN-2023 | AGM | Reappointment of Mr. R. Mukundan (DIN: 00778253) as Managing Director & CEO of the Company. |
| 26-JUN-2023 | AGM | To appoint a Director in place of Mr. N. Chandrasekaran (DIN: 00121863), who retires by rotation and being eligible, offers himself for re-appointment. |
| 26-JUN-2023 | AGM | To declare dividend on the Ordinary Shares for the financial year ended March 31, 2023. |
| 26-JUN-2023 | AGM | To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023, together with the Report of the Auditors thereon. |
| 23-MAR-2023 | Postal Ballot | Re-appointment of Ms. Padmini Khare Kaicker (DIN: 00296388) as an Independent Director of the Company |
| 23-MAR-2023 | Postal Ballot | Re-appointment of Mr. Zarir Langrana (DIN: 06362438) as an Executive Director of the Company |
| 06-JUL-2022 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Board of Directors and Auditors thereon. |
| 06-JUL-2022 | AGM | Re-appointment of Statutory Auditors of the Company |
| 06-JUL-2022 | AGM | To appoint a Director in place of Mr. S. Padmanabhan (DIN: 00306299), who retires by rotation and being eligible, offers himself for re-appointment. |
| 06-JUL-2022 | AGM | To declare dividend on the Ordinary Shares for the financial year ended March 31, 2022 |
| 06-JUL-2022 | AGM | To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022, together with the Report of the Auditors thereon. |
FAQs on Tata Chemicals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.